Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
369
datasets available to search
ShareScore release 0.9.0
Dataset results
369 results for “adalimumab”
A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in
ClinicalTrials.gov study NCT02499263. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
ClinicalTrials.gov study NCT01273519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice
ClinicalTrials.gov study NCT01692899. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
ClinicalTrials.gov study NCT01078571. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ClinicalTrials.gov study NCT06045754. IPD Sharing: YES. Countries: 2. Publications: 0.
An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
ClinicalTrials.gov study NCT01644396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
ClinicalTrials.gov study NCT02904902. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01231321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inade
ClinicalTrials.gov study NCT04909801. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With Adalimumab
ClinicalTrials.gov study NCT01752855. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
ClinicalTrials.gov study NCT00427362. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
ClinicalTrials.gov study NCT01783015. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study of Rheumatoid Arthritis Patients on Adalimumab to Evaluate Quality of Life Variables, Effects on Work Productivity and Functional Outcomes in Malaysia
ClinicalTrials.gov study NCT01387789. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
ClinicalTrials.gov study NCT01202565. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients as Assessed by Capsule Endoscopy
ClinicalTrials.gov study NCT01144156. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
ClinicalTrials.gov study NCT02130362. IPD Sharing: UNDECIDED. Countries: 22. Publications: 0.
A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge
ClinicalTrials.gov study NCT05884242. IPD Sharing: YES. Countries: 1. Publications: 0.
Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
ClinicalTrials.gov study NCT03306446. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Investigation of Immunological and Pharmacological Factors for Response to Adalimumab in Rheumatoid Arthritis
ClinicalTrials.gov study NCT03110094. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
ClinicalTrials.gov study NCT03153319. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.